MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03940nam a22002897a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
20241030200025.0 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20241030201146.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
241030b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
978-3-031-34846-4 |
|
|---|
| International Standard Book Number |
978-3-031-34847-1 (eBook) |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
0942-5373 |
|
|---|
| International Standard Serial Number |
2197-4187 (electronic) |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
ddc |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
English |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Fuller form of name |
Branislav Jeremić |
| 222 ## - KEY TITLE |
|---|
| Key title |
adenocarcinoma advanced non-small-cell lung amifostine angiogenesis bevacizumab brachytherapy brain metastases CALGB carboplatin cell lung cancer chemoradiation Chest cisplatin Clin Oncol combination concurrent chemotherapy CT disease docetaxel dose escalation effect EGFR endobronchial erlotinib esophagitis etoposide evaluation fractions gefitinib gemcitabine grade growth factor Gy hyperfractionated imaging improved induction chemotherapy inhibitor Int J Radiat Jeremic lesions locally advanced lung cancer NSCLC lung tumors lymph node median survival mediastinal metastases months non-small cell lung non-small-cell lung cancer normal tissue Oncol Biol Phys outcome overall survival paclitaxel patients with stage PCI pemetrexed PET phase II study phase III trial pleural prognostic prophylactic cranial irradiation pulmonary Radiat Oncol Biol Radiation Oncology radiation pneumonitis Radiation Therapy Oncology Radiother radiotherapy randomized trial recurrence regimens reported resection RT RTOG scans SCLC small cell small-cell lung cancer stent surgery surgical survival rates target volume thoracic radiation therapy thoracic radiotherapy tomography toxicity treatment planning tumor unresectable versus vinorelbine |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Advances in Radiation Oncology in Lung Cancer. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Third Edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
School of Medicine University of Kragujevac Kragujevac, Serbia | |
| Name of publisher, distributor, etc. |
Springer Nature Switzerland AG | |
| Date of publication, distribution, etc. |
2023 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1128 Pages |
| 490 ## - SERIES STATEMENT |
|---|
| Series statement |
Medical Radiology Radiation Oncology |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Although decades of laboratory and clinical research have led to incremental improvement in treatment outcome, lung cancer remains one of the most deadly diseases. In the second, completely updated edition of this comprehensive book, many of the world’s leading lung cancer specialists discuss the recent advances in the radiation oncology of lung cancer and reflect on the latest research findings. The first three sections cover the basic science of lung cancer, clinical investigations, including histology and staging, and a wide range of fundamental treatment considerations. Current treatment strategies for nonsmall cell and small cell lung cancer are then explained and evaluated in detail, with due attention to novel approaches that promise further improvements in outcome. The various types of treatment-related toxicity are discussed, and quality of life studies and prognostic factors are also considered. After evaluating the latest technological and biological advances, including IMRT, IMAT, cyber knife treatment, and tomotherapy, the book concludes by thorough consideration of specific aspects of clinical research in lung cancer. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| General subdivision |
Medical / Allied Health Services / Imaging Technologies, Medical / Biochemistry, Medical / Clinical Medicine, Medical / Oncology / General, Medical / Pulmonary & Thoracic Medicine, Medical / Radiology, Radiotherapy & Nuclear Medicine, Medical / Surgery / Cardiothoracic, Oncology, Radiology, Respiratory organs—Diseases, Surgery, Electronic books, Lungs -- Cancer -- Radiotherapy, Medical / Diagnostic Imaging / General, Medical / Internal Medicine, Medical / Oncology / Lung Cancer, Medical / Surgery / General, Chest -- Surgery, Imaging -- Radiology, Medical radiology, Medicine, Medicine and Public Health, Pneumology, Pneumology/Respiratory System, Radiotherapy, Respiratory organs -- Diseases. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href=" https://doi.org/10.1007/978-3-031-34847-1 "> https://doi.org/10.1007/978-3-031-34847-1 </a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
ddc |
| Koha item type |
E-BOOKS |
| Suppress in OPAC |
|
